VYREX CORP
NT 10-K, 1999-03-31
PHARMACEUTICAL PREPARATIONS
Previous: TTR INC, NT 10-K, 1999-03-31
Next: SPEED MERCHANT INC, S-4, 1999-03-31



<PAGE>




                                     UNITED STATES

                          SECURITIES AND EXCHANGE COMMISSION

                                WASHINGTON, D.C. 20549

                                      FORM 12b-25

                              NOTIFICATION OF LATE FILING

                                                            SEC FILE NUMBER
                                                               000-27866

                                                      (CHECK ONE)
                                                              CUSIP NUMBER
                                                           Common 92922E 10 1
                                                          Warrants 92922E 11 9

        /X/Form 10-K / /Form 20-F / /Form 11-K / /Form 10-Q / /Form N-SAR

                 For Period Ended:        December 31, 1998
                 /  / Transition Report on Form 10-K
                 /  / Transition Report on Form 20-F
                 /  / Transition Report on Form 11-K
                 /  / Transition Report on Form 10-Q
                 /  / Transition Report on Form N-SAR

                 For the Transition Period Ended:

  READ ATTACHED INSTRUCTION SHEET BEFORE PREPARING FORM. PLEASE PRINT OR TYPE.
    Nothing in this form shall be construed to imply that the Commission has 
               verified any information contained herein.

    If the notification relates to a portion of the filing checked above, 
           identify the Item(s) to which the notification relates:


<PAGE>

                          PART I -- REGISTRANT INFORMATION


Full Name of Registrant
                  Vyrex Corporation

Former Name if Applicable
                  n/a

Address of Principal Executive Office (STREET AND NUMBER)
                  2159 Avenida de la Playa

City, State and Zip Code
                  La Jolla, California 92037

                        PART II -- RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check box if appropriate)

       (a)  The reasons described in reasonable detail in Part III of this 
            form could not be eliminated without unreasonable effort or 
            expense; /X/

       (b)  The subject annual report, semi-annual report, transition report
            on Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof,
            will be filed on or before the fifteenth calendar day following
            the prescribed due date; or the subject quarterly report of 
            transition report on Form 10-Q, or portion thereof will be filed
            on or before the fifth calendar day following the prescribed due
            date; and [Amended in Release No. 34-26589, effective April 12, 
            1989, 54 F.R. 10306.] /X/

       (c)  The accountant's statement or other exhibit required by Rule
            12b-25(c) has been attached if applicable.

                             PART III -- NARRATIVE

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q,
N-SAR, or the transition report or portion thereof, could not be filed within 
the prescribed time period. [Amended in Release No. 34-26589, effective August 
13, 1992, 57 F.R. 36442.]

The Company was not able to complete the financial statements and information 
for the auditors without unreasonable efforts or expense.


<PAGE>

                           PART IV -- OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this
    notification

                 Martin Malk                       (619)       454-4446
                    (Name)                      (Area Code)(Telephone Number)

(2) Have all other periodic reports required under Section 13 or 15(d) of the
    Securities Exchange Act of 1934 or Section 30 of the Investment Company 
    Act of 1940 during the preceding 12 months or for such shorter period 
    that the registrant was required to file such report(s) been filed? If
    answer is no, identify report(s).                           /X/ Yes  / / No

(3) Is it anticipated that any significant change in results of operations 
    from the corresponding period for the last fiscal year will be reflected
    by the earnings statements to be included in the subject report or 
    portion thereof?                                            / / Yes  /X/ No

    If so, attach an explanation of the anticipated change, both narratively 
    and quantitatively, and, if appropriate, state the reasons why a reasonable
    estimate of the results cannot be made.


                              Vyrex Corporation
                 (Name of Registrant as Specified in Charter)

    has caused this notification to be signed on its behalf by the undersigned
    hereunto duly authorized.


    Date: March 30, 1999                        By  /s/ Martin Malk
                                                   ----------------------------
                                                   Martin Malk, Chief 
                                                   Financial Officer

INSTRUCTIONS: The form may be signed by an executive officer of the registrant 
or by any other duly authorized representative. The name and title of the 
person signing the form shall be typed or printed beneath the signature. If 
the statement is signed on behalf of the registrant by an authorized 
representative (other than an executive officer), evidence of the 
representative's authority to sign on behalf of the registrant shall be filed 
with the form.

                                    ATTENTION

  Intentional misstatements or omissions of fact constitute Federal Criminal
                      Violations (See 18 U.S.C. 1001).



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission